These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34160460)
1. Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose. Badarny S; Ibrahim R; Susel Z; Zaina A; Nasar R; Badarny Y Medicine (Baltimore); 2021 Jun; 100(25):e26481. PubMed ID: 34160460 [TBL] [Abstract][Full Text] [Related]
2. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870 [TBL] [Abstract][Full Text] [Related]
3. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. Wu CJ; Shen JH; Chen Y; Lian YJ Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Ababneh OH; Cetinkaya A; Kulwin DR Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601 [TBL] [Abstract][Full Text] [Related]
5. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S; Susel Z; Honigman S Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631 [TBL] [Abstract][Full Text] [Related]
6. [Changes in dose and injection pattern in the botulinum toxin long-term therapy of facial dyskinesis]. Laskawi R; Niemczewska A; Schneider S; Winterhoff J; Beutner C; Rohrbach S Laryngorhinootologie; 2014 Mar; 93(3):186-92. PubMed ID: 24323508 [TBL] [Abstract][Full Text] [Related]
7. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin]. Winterhoff J; Laskawi R HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435 [TBL] [Abstract][Full Text] [Related]
9. Use of Alleviating Maneuvers for Periocular Facial Dystonias. Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483 [TBL] [Abstract][Full Text] [Related]
10. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much? Pang AL; O'Day J Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340 [TBL] [Abstract][Full Text] [Related]
11. Dose conversion ratio, comparative efficacy, and adverse events after switching from onabotulinum toxin A to abobotulinum toxin A for neurological conditions. Ozer IS; Kuzu Kumcu M; Tezcan Aydemir S; Akbostanci MC Clin Neurol Neurosurg; 2021 Oct; 209():106889. PubMed ID: 34461363 [TBL] [Abstract][Full Text] [Related]
12. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. Kongsengdao S; Kritalukkul S J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887 [TBL] [Abstract][Full Text] [Related]
13. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443 [TBL] [Abstract][Full Text] [Related]
14. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Bentivoglio AR; Fasano A; Ialongo T; Soleti F; Lo Fermo S; Albanese A Eur J Neurol; 2009 Mar; 16(3):392-8. PubMed ID: 19364366 [TBL] [Abstract][Full Text] [Related]
15. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393 [TBL] [Abstract][Full Text] [Related]
16. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. Kollewe K; Mohammadi B; Dengler R; Dressler D J Neural Transm (Vienna); 2010 Jun; 117(6):759-63. PubMed ID: 20437061 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis. Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Nüssgens Z; Roggenkämper P Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885 [TBL] [Abstract][Full Text] [Related]
19. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1. Sampaio C; Ferreira JJ; Simões F; Rosas MJ; Magalhães M; Correia AP; Bastos-Lima A; Martins R; Castro-Caldas A Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]